Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery (NOTES)

December 12, 2014 updated by: Jeffrey Marks, MD, University Hospitals Cleveland Medical Center

Prospective Evaluation of the Intraoperative Use of Translumenal Flexible Endoscopes During Combined Flexible and Laparoscopic Foregut and Urologic Surgery

NOTES access is safe and feasible in the controlled human setting and comparable to standard-of-care surgical techniques. NOTES exploration of the abdomen provides adequate visualization comparable to laparoscopy.

Study Overview

Detailed Description

This is a prospective clinical trial to evaluate the feasibility of obtaining peritoneal cavity access from natural orifice translumenal endoscopic surgery (NOTES) during combined laparoscopic-endoscopic foregut surgery. Post-operative course will be compared with a historical chart-review control group of patients undergoing standard laparoscopic foregut and urologic surgery.

The study group will be compiled by open enrollment for male and female adult subjects scheduled for combined laparoscopic-endoscopic surgery of the stomach, abdominal esophagus, prostate, bladder, proximal small intestine or who meet inclusion and exclusion criteria. The historical chart-review control group will be randomly chosen from patients from 2003-2006 having undergone combined laparoscopic-endoscopic surgery of the foregut, prostate, or bladder and as determined by CPT coding.

The purpose of the study is to determine if NOTES access and abdominal exploration is feasible, safe, offers comparable visualization to laparoscopy in a controlled human setting.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44116
        • University Hospitals of Cleveland Case Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing an already combined laparoscopic and endoscopic foregut procedure with general anesthesia
  • Patients undergoing a prostatectomy or cystectomy with general anesthesia
  • All patients will have a planned gastrotomy for exploration, foreign body removal, or removal of tissue, making it a contaminated case or a planned cystotomy or urethrotomy for exploration, foreign body removal or removal of tissue such as prostatectomy or bladder resection.
  • No overwhelming medical co-morbidities
  • Subject is 18 years of age or older
  • Subject is his or her own medical decision maker
  • Subject agrees to participate, fully understands content of informed consent form, and signs the informed consent form

Exclusion Criteria:

  • Patients undergoing a non-palliative procedure in the face of resectable adenocarcinoma of the foregut or genitourinary tract
  • Linitis Plastica
  • Evidence of Active Bowel Obstruction
  • Patients with history of oropharyngeal, esophageal, or gastric adenocarcinoma.
  • Esophageal stricture prohibiting passage of an endoscope
  • Urethral stricture prohibiting passage of an endoscope
  • Emergent Surgery
  • At any time during pre-operative or intra-operative periods, evidence of unresectability is demonstrated
  • Any intra-operative condition prior to surgical resection that results in abortion of the surgical procedure
  • Any contraindication to surgery
  • Pregnancy or actively breastfeeding women
  • Prisoners or Wards of State

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prospective
Subjects scheduled to receive procedure
Patients will have the standard laparoscopic procedure and the NOTES procedure will be added. The surgical procedure will require two operating teams: one led by a laparoscopic surgeon, the other by an endoscopic surgeon. During the usual course of the surgery, the flexible endoscope will be passed through the mouth urethra top gain access to the peritoneal cavity.
Other Names:
  • NOTES Surgery
Other: Historical
Chart review control group
chart review of historical data from control group
Other Names:
  • NOTES Surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 day Post-op NOTES feasibility outcomes:
Time Frame: 30 days post-op
  • Number of successful NOTES access attempts
  • Number of failed NOTES access attempts
  • Injury to collateral organs or structures
  • Time to gain access to peritoneal cavity
  • Necessary balloon dilator size required for translumenal passage of endoscope
30 days post-op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
30 Day Post-OP Evaluation of Efficacy of NOTES access when compared to historical control groups undergoing laparoscopic access during foregut surgery
Time Frame: 30 Day Post-OP

Description: Mortality Post-Op Mobidity repeat sugery Intra-Op or Post-Op RBC Transfusion Intra-Abdominal Abscess Superficial Surgical Site Infection Antibiotics>24th Post-Op

Safety Issue?: Yes

30 Day Post-OP
30 Day NOTES Post - Op Evaluation of Adequacy of Abdominal Exploration
Time Frame: 30 Day Post - Op
Description: Identification of Specified Abdominal and Pelvic Organs Time to Adequately Visualize Specified Abdominal and Pelvic Organs Comparitive findings between standardaized abdominal exploration between laparoscopy and NOTES techniques
30 Day Post - Op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffrey M. Marks, MD, University Hospitals of Cleveland/ Institute for Surgical Innovation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2006

Primary Completion (Actual)

January 1, 2009

Study Completion (Actual)

January 1, 2009

Study Registration Dates

First Submitted

June 7, 2007

First Submitted That Met QC Criteria

June 8, 2007

First Posted (Estimate)

June 11, 2007

Study Record Updates

Last Update Posted (Estimate)

December 16, 2014

Last Update Submitted That Met QC Criteria

December 12, 2014

Last Verified

December 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prostatic Diseases

Clinical Trials on Natural Orifice Transluminal Endoscopic Surgery (NOTES)

Subscribe